G-CSF improves murine G6PC3-deficient neutrophil function by modulating

Blood

Volumn 117, Issue 14, 2011, Pages 3881-3892

  Sik Jun, Hyun ^a   Mok Lee, Young ^a   Duk Song, Ki ^b   Mansfield, Brian C ^a   Chou, Janice Y ^a  

^a Section on Cellular Differentiation   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ADENOSINE TRIPHOSPHATE; CALCIUM; CASPASE 3; CASPASE 9; CYTOCHROME C; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATASE BETA; GLUCOSE 6 PHOSPHATE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INITIATION FACTOR 2ALPHA; LACTIC ACID; LIPOCORTIN 5; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN KINASE B; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CALCIUM TRANSPORT; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENERGY BALANCE; ENZYME DEFICIENCY; GLUCOSE 6 PHOSPHATASE BETA DEFICIENCY; GLUCOSE TRANSPORT; KNOCKOUT MOUSE; MOUSE; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

EID: 79953818388     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-08-302059     Document Type: Article

References (49)

1. Shieh J-J, Pan C-J, Mansfield BC, Chou JY.Glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain agedependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem. 2003; 278(47):47098-47103. (Pubitemid 37452295)
2. Ghosh A, Shieh J-J, Pan C-J, Chou JY. Histidine- 167 is the phosphate acceptor in glucose-6- phosphatase-beta forming a phosphohistidineenzyme intermediate during catalysis. J Biol Chem. 2004;279(13):12479-12483. (Pubitemid 38445817)
3. Hiraiwa H, Pan C-J, Lin B, Moses SW, Chou JY. Inactivation of the glucose-6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem. 1999;274(9):5532-5536. (Pubitemid 29109201)
4. Chou JY, Matern D, Mansfield BC, Chen Y-T. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2002;2(2):121-143. (Pubitemid 34649836)
5. Chou JY, Mansfield BC. Glucose-6-phosphate transporter: the key to glycogen storage disease type Ib. In: Broer S, Wagner CA, eds. Membrane Transporter Diseases. New York, NY: Springer; 2003:191-205.
6. Kuijpers TW, Maianski NA, Tool AT, et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood. 2003;101(12):5021-5024. (Pubitemid 36857768)
7. Cheung YY, Kim SY, Yiu WH, et al. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase- beta. J Clin Invest. 2007;117(3):784-793.
8. Boztug K, Appaswamy G, Ashikov A, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med. 2009;360(1):32-43.
9. Kim SY, Jun HS, Mead PA, Mansfield BC, Chou JY. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood. 2008;111(12):5704-5711.
10. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005;74:739-789. (Pubitemid 40995523)
11. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 2004;11(2):372-380. (Pubitemid 38489415)
12. Rane MJ, Klein JB. Regulation of neutrophil apoptosis by modulation of PKB/Akt activation. Front Biosci. 2009;14:2400-2412.
13. Stiles BL. PI-3-K and AKT: onto the mitochondria. Adv Drug Deliv Rev. 2009;61(14):1276-1282.
14. Scheel-Toellner D, Wang KQ, Webb PR, et al. Early events in spontaneous neutrophil apoptosis. Biochem Soc Trans. 2004;32:461-464. (Pubitemid 38813537)
15. Visser G, Rake JP, Labrune P, Leonard JV, Ullrich,K, Smit GP. Granulocyte colonystimulating factor in glycogen storage disease type 1b: results of the European Study on Glycogen Storage Disease Type 1. Eur J Pediatr. 2002; 161(suppl 1):S83-S87.
16. Calderwood S, Kilpatrick L, Douglas SD, et al. Recombinant human granulocyte colonystimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood. 2001; 97(2):376-382. (Pubitemid 32060320)
17. McDermott DH, DeRavin SS, Jun HS, et al. Severe congenital neutropenia due to G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood. 2010;116(15): 2793-2802.
18. Cario G, Skokowa J, Wang Z, et al. Heterogeneous expression pattern of pro- and antiapoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol. 2005;129(2):275-278. (Pubitemid 40562449)
19. Maianski NA, Mul FP, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood. 2002;99(2): 672-679. (Pubitemid 34533107)
20. Maianski NA, Roos D, Kuijpers TW. Bid truncation, Bid/Bax targeting to the mitochondria, and caspase activation associated with neutrophil apoptosis are inhibited by granulocyte colonystimulating factor. J Immunol. 2004;172(11):7024-7030. (Pubitemid 38669144)
21. Jun HS, Lee YM, McDermott DH, et al. Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome. Blood. 2010;116(15):2783-2792.
22. McCawley LJ, Korchak HM, Douglas SD, et al. In vitro and in vivo effects of granulocyte colonystimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colonystimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2 mobilization. Pediatr Res. 1994;35(1):84-90. (Pubitemid 24004640)
23. Campos CB, Paim BA, Cosso RG, Castilho RF, Rottenberg H, Vercesi AE. Method for monitoringof mitochondrial cytochrome c release during cell death: immunodetection of cytochrome c by flow cytometry after selective permeabilization of the plasma membrane. Cytometry A. 2006;69(6):515-523. (Pubitemid 44651338)
24. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11(4):381-389. (Pubitemid 38489416)
25. Wymann MP, Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta. 1998;1436(1):127-150.
26. Downes CP, Bennett D, McConnachie G, et al. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. Biochem Soc Trans. 2001;29(6):846-851. (Pubitemid 33131792)
27. Sly LM, Ho V, Antignano F, et al. The role of SHIP in macrophages. Front Biosci. 2007;12:2836-2848.
28. Haynes CM, Titus EA, Cooper AA. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell. 2004;15(5):767-776. (Pubitemid 39194906)
29. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol. 2007;47: 143-183.
30. Yasui K, Baba A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm Res. 2006;55(9):359-363. (Pubitemid 44825292)
31. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139(5):1281-1292. (Pubitemid 27523214)
32. Hsu YT,Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci U S A. 1997;94(8):3668-3672.
33. Maianski NA, Geissler J, Srinivasula SM, Alnemri ES, Roos D, Kuijpers TW. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ. 2004;11(2):143-153. (Pubitemid 38159638)
34. van Raam BJ, Verhoeven AJ, Kuijpers TW. Mitochondria in neutrophil apoptosis. Int J Hematol. 2006;84(3):199-204. (Pubitemid 44619238)
35. Siegel RM. Caspases at the crossroads of immunecell life and death. Nat Rev Immunol. 2006;6:308-317.
36. Touw IP, van de Geijn GJ. Granulocyte colonystimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders. Front Biosci. 2007;12:800-815. (Pubitemid 46846857)
37. Tan AS, Ahmed N, Berridge MV. Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP, and granulocyte-macrophage colony-stimulating factor. Blood. 1998;91(2):649-655. (Pubitemid 28053390)
38. McCall CE, Bass DA, Cousart S, DeChatelet LR. Enhancement of hexose uptake in human polymorphonuclear leukocytes by activated complement component C5a. Proc Natl Acad Sci U S A. 1979;76(11):5896-5900. (Pubitemid 10216683)
39. Bloch R. Inhibition of glucose transport in the human erythrocyte by cytochalasin B. Biochemistry. 1973;12(23):4799-4801.
40. Kang HT, Hwang ES. 2-Deoxyglucose: an anticancer and antiviral therapeutic, but not any more a low glucose mimetic. Life Sci. 2006;78(12): 1392-1399. (Pubitemid 43199960)
41. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell. 2006;21(6):749-760. (Pubitemid 43376126)
42. Zhao Y, Altman BJ, Coloff JL, et al. Glycogen synthase kinase 3alpha and 3beta mediate a glucose- sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Mol Cell Biol. 2007;27(12):4328-4339. (Pubitemid 46906557)
43. Koh DW, Dawson TM, Dawson VL. Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res. 2005;52(5579):5-14. (Pubitemid 40725595)
44. Dhar-Mascareno M, Chen J, Zhang RH, Cárcamo JM, Golde DW. Granulocyte-macrophage colonystimulating factor signals for increased glucose transport via phosphatidylinositol 3-kinase- and hydrogen peroxide-dependent mechanisms. J Biol Chem. 2003;278(13):11107-11114. (Pubitemid 36792663)
45. Hewitt KN, Walker EA, Stewart PM. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11beta-hydroxysteroid dehydrogenase type 1 activity. Endocrinology. 2005;146(6):2539-2543. (Pubitemid 40695555)
46. Lavery GG, Walker EA, Draper N, et al. Hexose- 6-phosphate dehydrogenase knock-out mice lack 11beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem. 2006;281(10):6546-6551. (Pubitemid 43847588)
47. Tomlinson JW, Walker EA, Bujalska IJ, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004;25(5):831-866. (Pubitemid 39366049)
48. Chen L-Y, Shieh J-J, Lin B, et al. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum Mol Genet. 2003;12(19):2547-2558. (Pubitemid 37220419)
49. Edwards SW, Derouet M, Howse M, Moots RJ. Regulation of neutrophil apoptosis by Mcl-1. Biochem Soc Trans. 2004;32(3):489-492. (Pubitemid 38813545)